[1] 马山, 卢少海, 田景振.杜仲药效成分和药理学的研究概况[J].食品与药品, 2013, 15(6):449-451.
[2] ZHOU J F, ZHANG T M, CHEN W A, et al.Comparative analysis of chemical components between barks and leaves of Eucommia ulmoides Oliver[J].Journal of Central South University, 2009, 16(3):371-379.

[3] DO M H, HUR J, CHOI J, et al.Eucommia ulmoides ameliorates glucotoxicity by suppressing advanced glycation end-products in diabetic mice kidney[J].Nutrients, 2018, 10(3):265.
[4] 杨改青, 王林枫, 廉红霞, 等.杜仲叶对绵羊营养物质消化利用、生长性能及屠宰性能的影响[J].动物营养学报, 2017, 29(4):1383-1391.
[5] 孙燕荣, 董俊兴, 吕秋军, 等.杜仲对脂肪细胞糖代谢的影响[J].中医药学刊, 2004, 22(8):1552-1553.
[6] ZHANG Y Y, ZHANG H X, WANG F, et al.The ethanol extract of Eucommia ulmoides Oliv.leaves inhibits disaccharidase and glucose transport in Caco-2 cells[J].Journal of Ethnopharmacology, 2015, 163:99-105.
[7] JIN X, AMITANI K, ZAMAMI Y, et al.Ameliorative effect of Eucommia ulmoides Oliv.leaves extract (ELE) on insulin resistance and abnormal perivascular innervation in fructose-drinking rats[J].Journal of Ethnopharmacology, 2010, 128(3):672-678.

[8] 周芳, 刘韶, 邓梦如, 等.GC-MS/SIM法测定不同产地杜仲叶中的氨基酸[J].中南药学, 2012, 10(4):257-260.
[9] LEE M K, KIM M J, CHO S Y, et al.Hypoglycemic effect of Duzhong (Eucommia ulmoides Oliv.) leaves in streptozotocin-induced diabetic rats[J].Diabetes Research and Clinical Practice, 2005, 67(1):22-28.

[10] PARK S A, CHOI M S, KIM M J, et al.Hypoglycemic and hypolipidemic action of Duzhong (Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ-db/db mice[J].Journal of Ethnopharmacology, 2006, 107(3):412-417.

[11] 田吉, 岳永花, 秦大莲.杜仲叶降血糖作用的实验研究[J].现代医药卫生, 2011, 27(7):961-962.
[12] CAI Y, WANG Y, ZHI F, et al.The effect of sanggua drink extract on insulin resistance through the PI3K/AKT signaling pathway[J].Evidence-Based Complementary and Alternative Medicine, 2018, 2018:9407945.
[13] CHENG Z Y, TSENG Y, WHITE M.Insulin signaling meets mitochondria in metabolism[J].Trends in Endocrinology & Metabolism, 2010, 21(10):589-598.

[14] XIE W, YE Y L, FENG Y, et al.Linderane suppresses hepatic gluconeogenesis by inhibiting the cAMP/PKA/CREB pathway through indirect activation of PDE 3 via ERK/STAT3[J].Frontiers in Pharmacology, 2018, 9:476.
[15] 杨杰.磷酸果糖激酶相关微小RNA影响肿瘤细胞糖代谢的机制研究[D].硕士学位论文.宁波:宁波大学, 2015.
[16] WANG T, JIANG H M, CAO S J, et al.Baicalin and its metabolites suppresses gluconeogenesis through activation of AMPK or AKT in insulin resistant HepG-2 cells[J].European Journal of Medicinal Chemistry, 2017, 141:92-100.
[17] XIONG X P, SONG Q, HAN C C, et al.Insulin promotes the expression of the gluconeogenic rate-limiting enzymes phosphoenolpyruvate carboxykinase (Pepck) and glucose 6-phosphatase (G6pase) through PI3k/Akt/mTOR signaling pathway in goose hepatocytes[J].Revista Brasileira de Ciência Avícola, 2016, 18(3):395-400.

[18] NAKAE J, KITAMURA T, SILVER D L, et al.The forkhead transcription factor Foxo1(Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression[J].Journal of Clinical Investigation, 2001, 108(9):1359-1367.

[19] 张兰涛, 常翠青, 刘阳, 等.氯原酸对db/db小鼠糖脂代谢紊乱的影响及其作用机制[J].中国医学科学院学报, 2011, 33(3):281-286.
[20] SHI Y N, QIAO J Y, MU B, et al.3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2, 4-dione (K145) ameliorated dexamethasone induced hepatic gluconeogenesis through activation of Akt/FoxO1 pathway[J].Biochemical and Biophysical Research Communications, 2017, 493(1):286-290.

[21] WANG Q, WANG N, DONG M, et al.GdCl
3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice[J].Clinical Science, 2014, 127(2):91-100.

[22] SAMUEL V T, CHOI C S, PHILLIPS T G, et al.Targeting FoxO1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action[J].Diabetes, 2006, 55(7):2042-2050.

[23] SAMUEL V T, SHULMAN G I.The pathogenesis of insulin resistance:integrating signaling pathways and substrate flux[J].Journal of Clinical Investigation, 2016, 126(1):12-22.

[24] LEE J, KIM M S.The role of GSK3 in glucose homeostasis and the development of insulin resistance[J].Diabetes Research and Clinical Practice, 2007, 77(Suppl.3):S49-S57.
[25] XU H, ZHIOU Y, LIU Y X, et al.Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis[J].Journal of Endocrinology, 2016, 229(2):133-144.

[26] LIU T Y, SHI C X, GAO R, et al.Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes[J].Clinical Science, 2015, 129(10):839-850.